Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 17, 2024

BUY
$40.97 - $43.33 $2.29 Million - $2.43 Million
56,001 New
56,001 $2.37 Million
Q1 2024

Aug 16, 2024

SELL
$40.97 - $43.33 $17,821 - $18,848
-435 Reduced 0.77%
56,001 $2.37 Million
Q1 2024

May 15, 2024

SELL
$40.97 - $43.33 $17,821 - $18,848
-435 Reduced 0.77%
56,001 $2.37 Million
Q4 2023

Aug 16, 2024

BUY
$32.77 - $42.31 $1.85 Million - $2.39 Million
56,436 New
56,436 $2.36 Million
Q4 2023

Feb 13, 2024

BUY
$32.77 - $42.31 $109,582 - $141,484
3,344 Added 6.3%
56,436 $2.36 Million
Q3 2023

Nov 15, 2023

BUY
$35.46 - $40.13 $1.04 Million - $1.18 Million
29,392 Added 124.02%
53,092 $2 Million
Q2 2023

Aug 14, 2023

SELL
$24.24 - $40.97 $520,553 - $879,830
-21,475 Reduced 47.54%
23,700 $898,000
Q1 2023

May 15, 2023

BUY
$23.0 - $31.59 $21,919 - $30,105
953 Added 2.16%
45,175 $1.1 Million
Q4 2022

Feb 14, 2023

SELL
$27.6 - $32.99 $319,414 - $381,793
-11,573 Reduced 20.74%
44,222 $1.28 Million
Q3 2022

Nov 14, 2022

BUY
$28.74 - $39.9 $31,326 - $43,491
1,090 Added 1.99%
55,795 $1.67 Million
Q2 2022

Oct 27, 2022

BUY
$35.0 - $43.59 $1.55 Million - $1.93 Million
44,324 Added 426.97%
54,705 $1.98 Million
Q2 2022

Aug 15, 2022

BUY
$35.0 - $43.59 $1.55 Million - $1.93 Million
44,324 Added 426.97%
54,705 $1.98 Million
Q1 2022

Oct 27, 2022

SELL
$43.12 - $50.3 $1.91 Million - $2.23 Million
-44,324 Reduced 81.02%
10,381 $449,000
Q1 2022

May 13, 2022

SELL
$43.12 - $50.3 $262,471 - $306,176
-6,087 Reduced 36.96%
10,381 $449,000
Q4 2021

Feb 14, 2022

SELL
$47.6 - $65.0 $1.07 Million - $1.46 Million
-22,508 Reduced 57.75%
16,468 $825,000
Q3 2021

Nov 15, 2021

BUY
$62.34 - $73.38 $2.43 Million - $2.86 Million
38,976 New
38,976 $2.48 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.